New model aims to take the guesswork out of ventilator weaning for COPD patients
NCT ID NCT07579052
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study is developing and testing a new tool called the CLEAR model to help doctors predict when people with severe COPD can safely stop using a ventilator or non-invasive breathing support. Researchers will enroll 400 adults in the ICU and track how well the model predicts successful weaning within 72 hours. The goal is to improve decision-making and reduce the risk of breathing failure after support is removed.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could give doctors a more accurate way to decide when COPD patients can safely come off a ventilator, reducing complications and hospital stays.
- What could go wrong
- This is an early observational study, not a treatment trial. The model may not prove accurate enough to change practice, and results may not apply to all COPD patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC OBSTRUCTIVE PULMONARY DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Assuit Univeristy
RECRUITINGAsyut, Assuit Egypt, 71515, Egypt
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Smart breathing machines at home: a new way to predict COPD crises?
- Breathing easy? new X-Ray method may spot COPD decline early
- Could a common heart drug cut COPD hospitalizations?
- Which inhaler breathes better? a Head-to-Head COPD showdown
- Could tiny lung valves revive heart and muscle strength in COPD?
- One lung or two? surgery trial aims to find the best approach for severe COPD